Jacob Howard
HudsonAlpha Institute for Biotechnology, Huntsville, AL 35806, USA
Dis Model Mech. 2016 Oct 1;9(10):1073-1077. doi: 10.1242/dmm.027805.
Howard Jacob is best known for pioneering genomic sequencing of a patient to solve a mysterious pediatric case in 2010. With roots in pharmacology and cardiovascular disease, however, his career has largely been dedicated to dissecting the physiology and genetics of the rat to help understand complex human diseases. Howard was Director of the Human and Molecular Genetics Center at the Medical College of Wisconsin for 16 years, during which time he applied a combination of approaches, including quantitative genetics, integrative physiology and next-generation sequencing, in rat models to shed light on cardiovascular, metabolic and renal disorders. He was a key contributor to the genomic toolbox for rat research, and generated the first targeted-knockout rat models using zinc-finger-nuclease technology. He also contributed to sequencing of the rat genome and establishment of the Rat Genome Database. In this interview, Howard provides his perspectives on the past, present and future of rat-based translational research and explains why, despite his many successes as the leader of a rat group, he recently made the transition to clinical genomics.
霍华德·雅各布最为人所知的是,2010年他率先对一名患者进行基因组测序,以解决一个神秘的儿科病例。然而,源于药理学和心血管疾病领域,他的职业生涯主要致力于剖析大鼠的生理学和遗传学,以帮助理解复杂的人类疾病。霍华德在威斯康星医学院人类与分子遗传学中心担任了16年主任,在此期间,他在大鼠模型中应用了包括数量遗传学、整合生理学和下一代测序在内的多种方法,以阐明心血管、代谢和肾脏疾病。他是大鼠研究基因组工具包的关键贡献者,并使用锌指核酸酶技术生成了首个靶向敲除大鼠模型。他还为大鼠基因组测序和大鼠基因组数据库的建立做出了贡献。在这次采访中,霍华德阐述了他对基于大鼠的转化研究的过去、现在和未来的看法,并解释了为什么尽管他作为大鼠研究团队的领导者取得了诸多成功,但他最近还是转向了临床基因组学领域。